Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Iron for Erythropoietic Protoporphyria
NCT02979249Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Dec 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferrous sulfate in erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Change in Erythrocyte Protoporphyrin Levels at 12 months. Started Dec 2016; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
erythropoietic protoporphyria (EPP)X-linked protoporphyria (XLP)
Beyond the preview
Go deeper on NCT02979249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02979249.